Hicks Caitlin W, Selvarajah Shalini, Mathioudakis Nestoras, Sherman Ronald E, Hines Kathryn F, Black James H, Abularrage Christopher J
Division of Vascular Surgery and Endovascular Therapy, Department of Surgery, The Johns Hopkins Hospital, Baltimore, MD.
Center for Surgical Trials and Outcomes Research, Department of Surgery, The Johns Hopkins Hospital, Baltimore, MD.
Ann Vasc Surg. 2016 May;33:149-58. doi: 10.1016/j.avsg.2015.11.025. Epub 2016 Feb 22.
Costs related to diabetic foot ulcer (DFU) care are greater than $1 billion annually and rising. We sought to describe the impact of diabetes mellitus (DM) on foot ulcer admissions in the United States, and to investigate potential explanations for rising hospital costs.
The Nationwide Inpatient Sample (2005-2010) was queried using International Classification of Diseases, 9th Revision (ICD-9) codes for a primary diagnosis of foot ulceration. Multivariable analyses were used to compare outcomes and per-admission costs among patients with foot ulceration and DM versus non-DM.
In total, 962,496 foot ulcer patients were admitted over the study period. The overall rate of admissions was relatively stable over time, but the ratio of DM versus non-DM admissions increased significantly (2005: 10.2 vs. 2010: 12.7; P < 0.001). Neuropathy and infection accounted for 90% of DFU admissions, while peripheral vascular disease accounted for most non-DM admissions. Admissions related to infection rose significantly among DM patients (2005: 39,682 vs. 2010: 51,660; P < 0.001), but remained stable among non-DM patients. Overall, DM accounted for 83% and 96% of all major and minor amputations related to foot ulcers, respectively, and significantly increased cost of care (DM: $1.38 vs. non-DM: $0.13 billion/year; P < 0.001). Hospital costs per DFU admission were significantly higher for patients with infection compared with all other causes ($11,290 vs. $8,145; P < 0.001).
Diabetes increases the incidence of foot ulcer admissions by 11-fold, accounting for more than 80% of all amputations and increasing hospital costs more than 10-fold over the 5 years. The majority of these costs are related to the treatment of infected foot ulcers. Education initiatives and early prevention strategies through outpatient multidisciplinary care targeted at high-risk populations are essential to preventing further increases in what is already a substantial economic burden.
与糖尿病足溃疡(DFU)护理相关的费用每年超过10亿美元且呈上升趋势。我们试图描述糖尿病(DM)对美国足部溃疡住院情况的影响,并探究住院费用上升的潜在原因。
利用国际疾病分类第九版(ICD - 9)编码查询全国住院患者样本(2005 - 2010年),以获取足部溃疡的主要诊断信息。采用多变量分析比较足部溃疡合并DM患者与非DM患者的治疗结果及每次住院费用。
在研究期间,共有962,496例足部溃疡患者入院。总体入院率随时间相对稳定,但DM患者与非DM患者的入院比例显著增加(2005年:10.2比2010年:12.7;P < 0.001)。神经病变和感染占DFU入院病例的90%,而外周血管疾病占大多数非DM患者的入院原因。DM患者中与感染相关的入院人数显著增加(2005年:39,682例比2010年:51,660例;P < 0.001),但非DM患者中保持稳定。总体而言,DM分别占与足部溃疡相关的所有大截肢和小截肢病例的83%和96%,并显著增加了护理费用(DM:每年13.8亿美元比非DM:每年1.3亿美元;P < 0.001)。与所有其他病因相比,感染患者每次DFU入院的医院费用显著更高(11,290美元比8,145美元;P < 0.001)。
糖尿病使足部溃疡入院发生率增加了11倍,占所有截肢病例的80%以上,并使5年内住院费用增加了10倍以上。这些费用大部分与感染性足部溃疡的治疗有关。针对高危人群的门诊多学科护理教育举措和早期预防策略对于防止这一已构成重大经济负担的情况进一步恶化至关重要。